Corrigendum: Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders.

Front Mol Neurosci

Department of Pharmacology and Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, United States.

Published: December 2018

AI Article Synopsis

  • This text references the correction of an article identified by the DOI 10.3389/fnmol.2018.00387.
  • The correction likely addresses errors or inaccuracies found in the original publication.
  • Such corrections are common in academic publishing to ensure the integrity and reliability of scientific literature.

Article Abstract

[This corrects the article DOI: 10.3389/fnmol.2018.00387.].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302680PMC
http://dx.doi.org/10.3389/fnmol.2018.00444DOI Listing

Publication Analysis

Top Keywords

corrigendum metabotropic
4
metabotropic glutamate
4
glutamate receptor
4
receptor therapeutic
4
therapeutic target
4
target neurodevelopmental
4
neurodevelopmental disorders
4
disorders [this
4
[this corrects
4
corrects article
4

Similar Publications

Corrigendum: Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders.

Front Mol Neurosci

December 2018

Department of Pharmacology and Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, United States.

Article Synopsis
  • This text references the correction of an article identified by the DOI 10.3389/fnmol.2018.00387.
  • The correction likely addresses errors or inaccuracies found in the original publication.
  • Such corrections are common in academic publishing to ensure the integrity and reliability of scientific literature.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!